Article

Human RioK3 is a novel component of cytoplasmic pre-40S pre-ribosomal particles

Centre National de la Recherche Scientifique
RNA biology (Impact Factor: 5.38). 02/2012; 9(2):162-74. DOI: 10.4161/rna.18810
Source: PubMed

ABSTRACT Maturation of the 40S ribosomal subunit precursors in mammals mobilizes several non-ribosomal proteins, including the atypical protein kinase RioK2. Here, we have investigated the involvement of another member of the RIO kinase family, RioK3, in human ribosome biogenesis. RioK3 is a cytoplasmic protein that does not seem to shuttle between nucleus and cytoplasm via a Crm1-dependent mechanism as does RioK2 and which sediments with cytoplasmic 40S ribosomal particles in a sucrose gradient. When the small ribosomal subunit biogenesis is impaired by depletion of either rpS15, rpS19 or RioK2, a concomitant decrease in the amount of RioK3 is observed. Surprisingly, we observed a dramatic and specific increase in the levels of RioK3 when the biogenesis of the large ribosomal subunit is impaired. A fraction of RioK3 is associated with the non ribosomal pre-40S particle components hLtv1 and hEnp1 as well as with the 18S-E pre-rRNA indicating that it belongs to a bona fide cytoplasmic pre-40S particle. Finally, RioK3 depletion leads to an increase in the levels of the 21S rRNA precursor in the 18S rRNA production pathway. Altogether, our results strongly suggest that RioK3 is a novel cytoplasmic component of pre-40S pre-ribosomal particle(s) in human cells, required for normal processing of the 21S pre-rRNA.

Download full-text

Full-text

Available from: Michèle Caizergues-Ferrer, Aug 05, 2015
0 Followers
 · 
180 Views
  • Source
    • "Baumas (LBME), who identified RioK3 as a new member of the RIO kinase family involved in rRNA 18S production. She showed that RioK3 is associated in the cytoplasm with pre- 40S particles and seems to display a cytoplasmic function required for correct maturation of the 21S pre-rRNA (Baumas et al., 2012). "
    Research in Microbiology 05/2012; 163(5):309-15. DOI:10.1016/j.resmic.2012.05.007 · 2.83 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Glioblastoma, the most common primary malignant brain tumor, is incurable with current therapies. Genetic and molecular analyses demonstrate that glioblastomas frequently display mutations that activate receptor tyrosine kinase (RTK) and Pi-3 kinase (PI3K) signaling pathways. In , activation of RTK and PI3K pathways in glial progenitor cells creates malignant neoplastic glial tumors that display many features of human glioblastoma. In both human and , activation of the RTK and PI3K pathways stimulates Akt signaling along with other as-yet-unknown changes that drive oncogenesis. We used this glioblastoma model to perform a kinome-wide genetic screen for new genes required for RTK- and PI3K-dependent neoplastic transformation. Human orthologs of novel kinases uncovered by these screens were functionally assessed in mammalian glioblastoma models and human tumors. Our results revealed that the atypical kinases RIOK1 and RIOK2 are overexpressed in glioblastoma cells in an Akt-dependent manner. Moreover, we found that overexpressed RIOK2 formed a complex with RIOK1, mTor, and mTor-complex-2 components, and that overexpressed RIOK2 upregulated Akt signaling and promoted tumorigenesis in murine astrocytes. Conversely, reduced expression of RIOK1 or RIOK2 disrupted Akt signaling and caused cell cycle exit, apoptosis, and chemosensitivity in glioblastoma cells by inducing p53 activity through the RpL11-dependent ribosomal stress checkpoint. These results imply that, in glioblastoma cells, constitutive Akt signaling drives RIO kinase overexpression, which creates a feedforward loop that promotes and maintains oncogenic Akt activity through stimulation of mTor signaling. Further study of the RIO kinases as well as other kinases identified in our screen may reveal new insights into defects underlying glioblastoma and related cancers and may reveal new therapeutic opportunities for these cancers.
    PLoS Genetics 02/2013; 9(2):e1003253. DOI:10.1371/journal.pgen.1003253 · 8.17 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Abstract The production and processing of ribosomal RNA is a complex and well-coordinated nucleolar process for ribosome biogenesis. Progress in understanding nucleolar structure and function has lead to the unexpected discovery of the nucleolus as highly sensitive sensor of cellular stress and important regulator of the tumour suppressor p53. Inhibition of ribosomal RNA metabolism has been shown to activate a signalling pathway for p53 induction. This review elucidates the potential of classical and recently developed chemotherapeutic drugs to stabilise p53 by inhibiting nucleolar functions.
    Biological Chemistry 05/2013; 394(9). DOI:10.1515/hsz-2013-0153 · 2.69 Impact Factor
Show more